Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
100
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Cutaneous Mycobacterium chelonae in a Patient with Sjogren’s Syndrome

Lu Guo1 Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China
,
Sha Lv1 Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China
,
Jing Zeng1 Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China
,
Jiayu Yang2 Department of Obstetrics and Gynecology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, People’s Republic of China
,
Baihui Shan1 Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China
&
Fuqiu Li1 Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of ChinaCorrespondence[email protected]
Pages 4977-4981 | Published online: 26 Nov 2021

References

  • Wallace RJ Jr, Brown BA, Onyi GO, et al. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992;166:405–412. doi:10.1093/infdis/166.2.4051386098
  • Lin SS, Lee CC, Jang TN. Soft tissue infection caused by rapid growing mycobacterium following medical procedures: two case reports and literature review. Ann Dermatol. 2014;26:236–240. doi:10.5021/ad.2014.26.2.23624882980
  • Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. doi:10.1164/rccm.200604-571ST17277290
  • Bhattacharya J, Mohandas S, Goldman DL, et al. Nontuberculous mycobacterial infections in children. Pediatr Rev. 2019;40:179–190. doi:10.1542/pir.2018-013130936399
  • Brown-Elliott BA, Philley JV, Schlossberg D. Rapidly growing mycobacteria. Microbiol Spectr. 2017;5(1). doi:10.1128/microbiolspec.TNMI7-0027-2016
  • Lee WJ, Kang SM, Sung H, et al. Non-tuberculous mycobacterial infections of the skin: a retrospective study of 29 cases. J Dermatol. 2010;37:965–972. doi:10.1111/j.1346-8138.2010.00960.x21039785
  • Brito-Zeron P, Retamozo S, Ramos-Casals M. Phenotyping Sjogren’s syndrome: towards a personalised management of the disease. Rheumatol Int. 2018;36:S198–S209.
  • Price EJ, Baer AN. How to treat Sjogren’s syndrome. Rheumatology. 2021;60:2574–2587. doi:10.1093/rheumatology/key363
  • Dow CT, Chan ED. What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren’s syndrome? J Transl Autoimmun. 2021;4:100085. doi:10.1016/j.jtauto.2021.10008533665595
  • Chao W-C, Lin C-H, Liao T-L, et al. Association between a history of mycobacterial infection and the risk of newly diagnosed Sjogren’s syndrome: a nationwide, population-based case-control study. PLoS One. 2017;12:e0176549. doi:10.1371/journal.pone.017654928486537
  • Nezos A, Gravani F, Tassidou A, et al. Type I and II interferon signatures in Sjogren’s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren’s related lymphomagenesis. J Autoimmun. 2015;63:47–58. doi:10.1016/j.jaut.2015.07.00226183766
  • Rayamajhi M, Humann J. Induction of IFN alpha beta enables Listeria monocytogenes to suppress macrophage activation by IFN gamma. Virulence. 2010;1(5):418–422. doi:10.4161/viru.1.5.1278721178482

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.